Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival

Sporadic colorectal cancer (sCRC) initially presents as metastatic tumors in 25–30% of patients. The 5-year overall survival (OS) in patients with metastatic sCRC is 50%, falling to 10% in patients presenting with synchronous metastatic disease (stage IV). In this study, we systematically analyzed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayagués, José María, Montero, Juan Carlos, Jiménez-Pérez, Andrea, del Carmen, Sofía, Rodríguez, Marta, Vidal Tocino, Rosario, Montero, Enrique, Sanz, Julia, Abad, Mar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179090/
https://www.ncbi.nlm.nih.gov/pubmed/37176143
http://dx.doi.org/10.3390/ijms24098438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179090/
https://www.ncbi.nlm.nih.gov/pubmed/37176143
http://dx.doi.org/10.3390/ijms24098438

Ejemplares similares